Evidence Supporting the Superiority of Intraperitoneal Cisplatin Compared to Intraperitoneal Carboplatin for Salvage Therapy of Small-Volume Residual Ovarian Cancer
Authors:
- Bonnie ReichmanBRBonnie Reichman
- Tom HakesTHTom Hakes
- Stephen RubinSRStephen Rubin
- John L. LewisJLJohn L. Lewis
- Walter JonesWJWalter Jones
- Richard BarakatRBRichard Barakat
- John CurtinJCJohn Curtin
- Lois AlmadronesLALois Almadrones
- William HoskinsWHWilliam Hoskins
- 1 July 1993
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 50 (1) , 100-104